Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2017
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937
Elizabeth M Gore, Chen Hu, Alexander Y Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2021
Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
David W Andrews, Kevin D Judy, Charles B Scott, et al.
Neuro-Oncology
|
November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma
Antonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
Noelle L Williams, Evan J Wuthrick, Hyun Kim, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Journal of Neuro-Oncology
|
November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2017
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937
Elizabeth M Gore, Chen Hu, Alexander Y Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2021
Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
David W Andrews, Kevin D Judy, Charles B Scott, et al.
Neuro-Oncology
|
November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma
Antonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
Noelle L Williams, Evan J Wuthrick, Hyun Kim, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Journal of Neuro-Oncology
|
November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
Page
of 16